DEA schedule
Is buprenorphine a controlled substance?
Federal schedule for buprenorphine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Buprenorphine is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Buprenorphine (Schedule III).
Run it in Rivvi
Which 2027 plans near you dropped or restricted buprenorphine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 107 prescription listings from 33 labelers, all Schedule III |
| DEA controlled substances list | Buprenorphine: Schedule III |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Buprenorphine | 9064 | III | Yes | Buprenex; Temgesic; Subutex; Suboxone | Listed by name |
Buprenorphine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 59385-022 | BELBUCA | film, soluble | 150 ug/1 | BioDelivery Sciences International Inc | CIII |
| 59385-023 | BELBUCA | film, soluble | 300 ug/1 | BioDelivery Sciences International Inc | CIII |
| 59385-024 | BELBUCA | film, soluble | 450 ug/1 | BioDelivery Sciences International Inc | CIII |
| 59385-025 | BELBUCA | film, soluble | 600 ug/1 | BioDelivery Sciences International Inc | CIII |
| 59385-021 | BELBUCA | film, soluble | 75 ug/1 | BioDelivery Sciences International Inc | CIII |
| 59385-026 | BELBUCA | film, soluble | 750 ug/1 | BioDelivery Sciences International Inc | CIII |
| 59385-027 | BELBUCA | film, soluble | 900 ug/1 | BioDelivery Sciences International Inc | CIII |
| 58284-228 | BRIXADI | injection | 128 mg/.36mL | Braeburn Inc. | CIII |
| 58284-216 | BRIXADI | injection | 16 mg/.32mL | Braeburn Inc. | CIII |
| 58284-224 | BRIXADI | injection | 24 mg/.48mL | Braeburn Inc. | CIII |
| 58284-232 | BRIXADI | injection | 32 mg/.64mL | Braeburn Inc. | CIII |
| 58284-264 | BRIXADI | injection | 64 mg/.18mL | Braeburn Inc. | CIII |
| 58284-208 | BRIXADI | injection | 8 mg/.16mL | Braeburn Inc. | CIII |
| 58284-296 | BRIXADI | injection | 96 mg/.27mL | Braeburn Inc. | CIII |
| 59011-751 | Butrans | patch, extended release | 10 ug/h | Knoa Pharma LLC | CIII |
| 59011-758 | Butrans | patch, extended release | 15 ug/h | Knoa Pharma LLC | CIII |
| 59011-752 | Butrans | patch, extended release | 20 ug/h | Knoa Pharma LLC | CIII |
| 59011-750 | Butrans | patch, extended release | 5 ug/h | Knoa Pharma LLC | CIII |
| 59011-757 | Butrans | patch, extended release | 7.5 ug/h | Knoa Pharma LLC | CIII |
| 12496-0100 | SUBLOCADE | solution | 100 mg/1 | Indivior Inc. | CIII |
| 12496-0300 | SUBLOCADE | solution | 300 mg/1 | Indivior Inc. | CIII |
| 42858-493 | Buprenorphine | patch | 10 ug/h | Rhodes Pharmaceuticals LLC | CIII |
| 42858-586 | Buprenorphine | patch | 15 ug/h | Rhodes Pharmaceuticals LLC | CIII |
| 42858-839 | Buprenorphine | patch | 20 ug/h | Rhodes Pharmaceuticals LLC | CIII |
| 42858-750 | Buprenorphine | patch | 5 ug/h | Rhodes Pharmaceuticals LLC | CIII |
| 42858-353 | Buprenorphine | patch | 7.5 ug/h | Rhodes Pharmaceuticals LLC | CIII |
| 0093-3657 | Buprenorphine | patch, extended release | 10 ug/h | Teva Pharmaceuticals USA, Inc. | CIII |
| 3215-1523 | Buprenorphine | patch, extended release | 10 ug/h | Aveva Drug Delivery Systems Inc. | CIII |
| 50742-374 | Buprenorphine | patch, extended release | 10 ug/h | INGENUS PHARMACEUTICALS, LLC | CIII |
| 69238-1203 | Buprenorphine | patch, extended release | 10 ug/h | Amneal Pharmaceuticals NY LLC | CIII |
| 0093-3658 | Buprenorphine | patch, extended release | 15 ug/h | Teva Pharmaceuticals USA, Inc. | CIII |
| 3215-1524 | Buprenorphine | patch, extended release | 15 ug/h | Aveva Drug Delivery Systems Inc. | CIII |
| 50742-375 | Buprenorphine | patch, extended release | 15 ug/h | INGENUS PHARMACEUTICALS, LLC | CIII |
| 69238-1204 | Buprenorphine | patch, extended release | 15 ug/h | Amneal Pharmaceuticals NY LLC | CIII |
| 0093-3659 | Buprenorphine | patch, extended release | 20 ug/h | Teva Pharmaceuticals USA, Inc. | CIII |
| 3215-1525 | Buprenorphine | patch, extended release | 20 ug/h | Aveva Drug Delivery Systems Inc. | CIII |
| 50742-376 | Buprenorphine | patch, extended release | 20 ug/h | INGENUS PHARMACEUTICALS, LLC | CIII |
| 69238-1205 | Buprenorphine | patch, extended release | 20 ug/h | Amneal Pharmaceuticals NY LLC | CIII |
| 0093-3656 | Buprenorphine | patch, extended release | 5 ug/h | Teva Pharmaceuticals USA, Inc. | CIII |
| 3215-1521 | Buprenorphine | patch, extended release | 5 ug/h | Aveva Drug Delivery Systems Inc. | CIII |
Showing 40 of 107 listings.
Questions
Is buprenorphine a controlled substance?
Yes. Buprenorphine is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Buprenorphine (Schedule III).
Is buprenorphine a narcotic?
Yes. The DEA list marks buprenorphine as a narcotic (NARC = Y) and places it in Schedule III. Its FDA established pharmacologic class is Partial Opioid Agonist.
What schedule is buprenorphine?
Buprenorphine is Schedule III in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Buprenorphine
- What is Buprenorphine used for?FDA label uses
- Generic for ButransFDA Orange Book
- Generic for BelbucaFDA Orange Book
- Generic for BuprenexFDA Orange Book
- Generic for BrixadiFDA Orange Book
- Generic for SublocadeFDA Orange Book
- Generic for SubutexFDA Orange Book
- What is Belbuca used for?FDA label uses
- Is Belbuca a controlled substance?Schedule III
- What is Butrans used for?FDA label uses
- Is Butrans a controlled substance?Schedule III
- What is Sublocade used for?FDA label uses
- Is Sublocade a controlled substance?Schedule III
- What is Brixadi used for?FDA label uses
- Is Brixadi a controlled substance?Schedule III
- Partial Opioid Agonists listFDA drug class